No abstract available
MeSH terms
-
Acute Coronary Syndrome / etiology
-
Anti-Infective Agents / therapeutic use
-
Arterial Occlusive Diseases / etiology*
-
Arterial Occlusive Diseases / physiopathology
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Incidence
-
Phospholipases A2, Secretory / antagonists & inhibitors
-
Protein C / therapeutic use
-
Recombinant Proteins / therapeutic use
-
Sepsis / complications*
-
Sepsis / drug therapy
-
Sepsis / physiopathology
-
Severity of Illness Index
-
Stroke / etiology
-
Thromboembolism / etiology*
-
Thromboembolism / physiopathology
-
Thromboembolism / prevention & control
-
Time Factors
-
Venous Thromboembolism / etiology*
-
Venous Thromboembolism / physiopathology
Substances
-
Anti-Infective Agents
-
Enzyme Inhibitors
-
Protein C
-
Recombinant Proteins
-
Phospholipases A2, Secretory
-
drotrecogin alfa activated